BPC-157, KPV, TB-500, MOTS-c, emideltide (DSIP), Epitalon, and Semax are on FDA's July 23–24, 2026 PCAC agenda.
Seven peptides. Fourteen questions. Two days of votes.
The July 2026 Pharmacy Compounding Advisory Committee meeting brings BPC-157, KPV, TB-500, MOTS-c, emideltide, Epitalon, and Semax before the committee for Section 503A Bulks List recommendations.
Follow the meeting on Rebody's PCAC live stream and peptide vote tracker.
The seven PCAC peptides
- BPC-157 — free base and acetate
- KPV — free base and acetate
- TB-500 — free base and acetate
- MOTS-c — free base and acetate
- Emideltide (DSIP) — free base and acetate
- Epitalon — free base and acetate
- Semax — free base and acetate
FDA scheduled one question for each form, creating 14 opportunities for favorable recommendations.
July 23 PCAC peptide schedule and results
Day 1 centers on BPC-157, KPV, TB-500, and MOTS-c.
- BPC-157 free base: favorable, 8 yes / 6 no / 1 abstention
- BPC-157 acetate: favorable, 8 yes / 6 no / 1 abstention
- KPV: favorable committee recommendation
- TB-500: favorable, 8 yes / 6 no / 1 abstention
- MOTS-c: result tracked on the live board
The first three peptides produced a powerful run of favorable results for the 503A Bulks List.
July 24 PCAC peptide schedule
The July 24 meeting starts at 8 a.m. Eastern and covers:
- Emideltide, also called delta sleep-inducing peptide or DSIP
- Epitalon
- Semax
Each peptide has a free-base question and an acetate question.
PCAC peptide testimony that defined Day 1
Dr. Alex Tatem presented aggregated real-world data covering more than 16 million doses of BPC-157. Seven complaints were identified, with no clear attributable adverse safety signal.
During the TB-500 hearing, he also presented data covering nearly 190,000 TB-500-containing vials, seven complaints, one involving standalone TB-500, and none serious.
Read the dedicated stories on the BPC-157 testimony and TB-500 testimony.
Watch the PCAC peptide meeting
Rebody's live tracker keeps the official streams, peptide list, schedule, and current results together.
PCAC peptides FAQ
Which peptides are at the July 2026 PCAC meeting?
BPC-157, KPV, TB-500, MOTS-c, emideltide (DSIP), Epitalon, and Semax.
How many PCAC peptide votes are scheduled?
FDA scheduled 14 questions: a free-base and acetate question for each of seven peptides.
Where can I watch the PCAC peptide meeting?
FDA streams both meeting days on YouTube, and Rebody's live tracker links to both official webcasts.